Live healthier, stronger and sharper for longer
Short, frequent pieces on what changed in the science of ageing well — and our research library holds the deep dives.
PeptidesARA-290 (Cibinetide): 2026 Evidence & Neuropathic Pain Relief
Unpack the newest 2026 evidence surrounding ARA-290 (Cibinetide), focusing on its impact on neuropathic pain, inflammation, and potential revised clinical recommendations.
PeptidesSS-31 (Elamipretide) & Longevity Biomarkers: Insights for 2026
This comprehensive analysis delves into SS-31 (Elamipretide)'s potential to influence critical longevity biomarkers, offering a nuanced perspective on its evidence base as of 2026.
PeptidesARA-290 (Cibinetide): Latest Evidence &
Discover the most recent clinical evidence on ARA-290 (Cibinetide), focusing on its applications in neuropathy and anti-inflammatory pathways, with updated insights for 2026.
PeptidesARA-290 for Healthy Ageing After 50 in 2026: An
Could ARA-290 be a valuable tool for healthy ageing? This expert analysis focuses on its benefits and considerations for individuals over 50, exploring its anti-inflammatory and reparative properties.
PeptidesARA-290 & Longevity Biomarkers: 2026
Exploring ARA-290's influence on crucial longevity biomarkers, this article dissects the evidence behind its potential to modulate inflammation and cellular ageing pathways.
PeptidesPinealon and Longevity Biomarkers: What the
Pinealon, a tripeptide, is hypothesised to influence longevity pathways. We examine its potential effects on epigenetic clocks, inflammatory markers, and other key biomarkers.
PeptidesBPC-157 & Longevity Biomarkers: Unpacking
A deep dive into BPC-157's effects on crucial longevity biomarkers, evaluating the current scientific landscape and what it means for your healthspan aspirations.
Wondering where to start?
Two minutes, no blood test, no sign-up — find out how you are actually ageing, and what to do about it.
The Sunday briefing
One email a week: what changed in the evidence, what it means for the markers you track, and the occasional thing worth stopping. No spam, unsubscribe anytime.